5-aminolevulinic

5-Aminolevulinic acid is an intermediate in heme synthesis which is the first compound in the porphyrin synthesis pathway.It is a photosensitizing agent, an antineoplastic agent and a prodrug.It can also be used (in the form of the hydrochloride salt)in combination with blue light illumination for the treatment of minimally to moderately thick actinic keratosis of the face or scalp.

5-Aminolevulinic acid hydrochloride (5-ALA) is an intermediate in heme biosynthesis and a universal precursor of tetrapyrroles.

5-Aminolevulinic acid-d2 (hydrochloride) is the deuterated form of 5-Aminolevulinic acid (hydrochloride). 5-Aminolevulinic acid hydrochloride (5-ALA hydrochloride) serves as an intermediate in the biosynthesis of heme in the body and acts as a precursor to tetrapyrroles.

5-Aminolevulinic acid-13C-1 (5-ALA-13C-1) hydrochloride is the 13C-labeled form of 5-Aminolevulinic acid hydrochloride. 5-Aminolevulinic acid hydrochloride (5-ALA hydrochloride) serves as an intermediate in the biosynthesis of heme within the body and acts as a precursor to tetrapyrroles.

(-)-Menthyl acetate exhibits broad-spectrum antibacterial activity, with minimum inhibitory concentrations (MIC) ranging from 0.12 to 8.0 μL/mL against pathogenic fungi such as Candida albicans and Aspergillus niger. It also inhibits fungal biofilm formation. (-)-Menthyl acetate enhances the skin permeability of 5-aminoacetopropionic acid, making it a potential tool for studying transdermal drug absorption.

Methyl Aminolevulinate Hydrochloride (5-Aminolevulinic acid methyl ester) is commonly used in photosentizer reagents for photodynamic therapy to treat conditions such as Acne vulgaris and hypertrophic scarring.

Hexaminolevulinate hydrochloride (P-1206) has approved for cystoscopic detection of papillary bladder cancer and it also is a fluorescent agent.

Protoporphyrin IX disodium, as a radiation sensitizer, enhances the production of ROS and induces DNA damage even under hypoxic conditions. It also acts as a photosensitizer, undergoing direct degradation through photobleaching upon light exposure. This compound accumulates in rat tumor cells following administration of 5-aminolevulinic acid (5-ALA). When activated with a peak wavelength of 405 nm, Protoporphyrin IX disodium selectively improves basal cell carcinoma. It shows promise in pharmacological research of sonodynamic and photodynamic therapy for cancers such as bladder cancer and nodular basal cell carcinoma.